Physician profile
Brian K Foster
NPI 1598261885
$2,582.64
in general payments reported to CMS, 2019-2025
10 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $1,960 · 2024: $342 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,710 · Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,710.06 |
| Food and Beverage | $729.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $1,710.06 | 2023 | |
| Arthrex, INC. | $232.00 | 2024 | |
| Stryker Corporation | $210.81 | 2023 | Mako, Tritanium, X3 |
| Medtronic, INC. | $125.98 | 2022 | |
| United Therapeutics Corporation | $113.63 | 2025 | |
| Active Medical, LLC | $110.30 | 2024 | |
| Skeletal Dynamics INC | $23.67 | 2025 | Align, Implate, Ijs |
| Sanara Medtech INC. | $22.13 | 2023 | Celleraterx |
| Rayner Intraocular Lenses Limited | $17.31 | 2022 | |
| Endo Pharmaceuticals INC. | $16.75 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.